Tecomet appoints Andreas Weller to corner office
04 Jan 2023
Executive Change
Contract manufacturer Tecomet announced today that it appointed Andreas Weller as its new president and CEO.
Weller succeeds former CEO and current chair of the Tecomet board, Bill Dow. Dow served as interim CEO at the manufacturer of orthopedic implants, instruments and sterilization trays since June 2022.
“The Search Committee conducted a thorough exploration, reviewing numerous profiles and interviewing many qualified candidates,” Dow said in a news release. “Andreas is the best of a select group. He has extensive experience successfully running manufacturing companies around the world. We are very pleased to welcome Andreas as the new leader of the Tecomet team.”
Wilmington, Massachusetts-based Tecomet also develops scalable manufacturing solutions for medical device technology, as well as aerospace and defense companies. Its capabilities include forging, casting, machining, photochemical etching, welding and finishing. It is a portfolio company of Charlsbank Capital Partners.
Weller brings to Tecomet more than 25 years of experience, including seven with The Boston Consulting Group. He also spent 20 years in roles of increasing responsibility in the contract manufacturing industry.
Most recently, Weller served as president and CEO of Aludyne.
“Tecomet has a long history as a steadfast partner to the medical device industry, including the top medical device and orthopedic companies,” Weller said. “I look forward to joining this talented management team and helping the company continue to build on its culture of excellence. Tecomet stands out in the field for its relentless focus on precision, rigorous standard of quality, and commitment to collaboration with its global customers.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.